Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Amgen Inc. (AMGN)

202.77 0.43 (0.21%)

10-17 16:00

Open:

201.41

Pre. Close:

202.34

High:

203.31

Low:

198.94

Volume:

1,905,209

Market Cap:

131247M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

203.574 - 204.397

204.397 - 205.18

Low:

196.891 - 197.805

197.805 - 198.675

Close:

201.304 - 202.74

202.74 - 204.108

Technical analysis  (as of: 2018-10-17 4:31:27 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 245.50     One year: 286.75

Support:

Support1: 199.18    Support2: 192.38

Resistance:

Resistance1: 210.19    Resistance2: 245.50

Pivot:

203.32

Moving Averages:

MA(5): 198.39     MA(20): 204.03

MA(100): 194.62     MA(250): 184.49

MACD:

MACD(12,26): -0.37     Signal(12,26,9): 0.42

%K %D:

%K(14,3): 44.10     %D(3): 32.09

RSI:

RSI(14): 51.46

52-Week:

High: 210.19  Low: 163.31  Change(%): 10.1

Average Vol(K):

3-Month: 251935  10-Days 283834

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AMGN has closed above bottom band by 46.9%. Bollinger Bands are 79.5% wider than normal. The large width of the bands suggest high volatility as compared to AMGN's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

2018-10-17T07:57:00-04:00
Stocks making the biggest move premarket: NFLX, IBM, CSX, UAL, TEVA & more

2018-10-17T07:28:37-04:00
Teva down 4% premarket on Express Scripts snub of migraine med Ajovy

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

647.27

Shares Float (M)

644.46

% Held by Insiders

% Held by Institutions

86.40

Shares Short (K)

10244

Shares Short Prior Month (K)

Stock Financials

EPS

13.460

EPS Est. Current Year

12.670

EPS Est. Next Year

12.790

EPS Est. Next Quarter

3.140

Forward EPS

14.224

Book Value (p.s.)

8.420

PEG Ratio

2.57

Profit Margin

1.99

Operating Margin

45.89

Return on Assets (ttm)

3.2

Return on Equity (ttm)

10.0

Qtrly Rev. Growth

4.3

Gross Profit (p.s.)

14.717

Sales Per Share

EBITDA (p.s.)

10.081

Qtrly Earnings Growth

6.70

Operating Cash Flow (M)

11290.00

Levered Free Cash Flow (M)

8550.00

Valuation

P/E

15.06

P/E Growth Ratio

P/BV

24.08

P/S

3984424448.00

P/CF

11.63

Dividend Yield

0.01

Dividends & Splits

Dividend

2.675

Dividend Pay Date

2018-09-07

Ex-Dividend Date

2018-08-16

Forward Dividend

5.280

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.